[Anti-angina effectiveness of sustak and obzidan in the acute period of myocardial infarct]. 1980

V G Kavtaradze, and K V Iosava, and P T Machavariani, and M V Kveselava

Sustak and obsidan were given separately and in combination to 99 patients with acute myocardial infarction and frequent attacks of angina pectoris. With the use of these agents the attacks of angina pectoris were very rare. The course of the disease and the prognosis were more favourable in the group of patients treated with anti-anginal agents than in the control group (100 patients).

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000787 Angina Pectoris The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION. Angor Pectoris,Stenocardia,Stenocardias

Related Publications

V G Kavtaradze, and K V Iosava, and P T Machavariani, and M V Kveselava
October 1980, Kardiologiia,
V G Kavtaradze, and K V Iosava, and P T Machavariani, and M V Kveselava
December 1989, Vrachebnoe delo,
V G Kavtaradze, and K V Iosava, and P T Machavariani, and M V Kveselava
March 1988, Vrachebnoe delo,
V G Kavtaradze, and K V Iosava, and P T Machavariani, and M V Kveselava
March 1984, Klinicheskaia meditsina,
V G Kavtaradze, and K V Iosava, and P T Machavariani, and M V Kveselava
December 1982, Kardiologiia,
V G Kavtaradze, and K V Iosava, and P T Machavariani, and M V Kveselava
July 1984, Biulleten' eksperimental'noi biologii i meditsiny,
V G Kavtaradze, and K V Iosava, and P T Machavariani, and M V Kveselava
September 1976, Revista clinica espanola,
V G Kavtaradze, and K V Iosava, and P T Machavariani, and M V Kveselava
January 1992, Vnitrni lekarstvi,
V G Kavtaradze, and K V Iosava, and P T Machavariani, and M V Kveselava
January 1977, Khirurgiia,
V G Kavtaradze, and K V Iosava, and P T Machavariani, and M V Kveselava
August 1988, Kardiologiia,
Copied contents to your clipboard!